Hospitals across the country have put great effort into reducing the risk of sepsis. Caused by an overwhelming immune response to infection, sepsis rates have steadily been on the rise in the country.
Now, a new Duke Health-developed artificial intelligence system promises a way of early detection of sepsis, a key step toward reducing cases and reining in costs. It’s part of Duke Health’s efforts to improve health care practices across the country.
And there are plans to expand the effort across the globe. Cohere Med, a clinical analytics company based in the US and India has licensed the technology from Duke. Cohere Med’s is expected to enhance the technology and make it available for health systems concerned with critical care.
For more information, read the story from Duke Licensing & Ventures.